Also from this source


You just read:

Cleveland HeartLab Adds New Patent to its Extensive Intellectual Property Position for the Myeloperoxidase (MPO) Test, a Powerful Biomarker for Inflammation and its Role in Major Cardiac Events

News provided by

Cleveland HeartLab Inc.

Feb 22, 2017, 08:00 ET